Compare SRRK & IBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | IBP |
|---|---|---|
| Founded | 2012 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.3B |
| IPO Year | 2018 | 2014 |
| Metric | SRRK | IBP |
|---|---|---|
| Price | $47.49 | $224.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 8 |
| Target Price | $56.17 | ★ $266.14 |
| AVG Volume (30 Days) | ★ 1.0M | 373.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | N/A | ★ 6.70 |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $2,970,800,000.00 |
| Revenue This Year | N/A | $1.96 |
| Revenue Next Year | $534.24 | $4.32 |
| P/E Ratio | ★ N/A | $172.82 |
| Revenue Growth | N/A | ★ 1.00 |
| 52 Week Low | $27.07 | $193.11 |
| 52 Week High | $58.49 | $349.00 |
| Indicator | SRRK | IBP |
|---|---|---|
| Relative Strength Index (RSI) | 39.11 | 49.82 |
| Support Level | $45.83 | $210.84 |
| Resistance Level | $48.23 | $232.50 |
| Average True Range (ATR) | 2.20 | 9.82 |
| MACD | -0.65 | -0.09 |
| Stochastic Oscillator | 5.15 | 47.59 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.